APO Research
Talk to an analyst

APO RESEARCH · REPORT

Typhoid Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Typhoid Vaccine Market Outlook and Growth Opportunities 2026

26 December 2025193 pages

Choose your research edition.

Industry ResearchTyphoid Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Typhoid Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Typhoid Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Typhoid Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Typhoid Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Typhoid Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Typhoid Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Typhoid Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Typhoid Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Typhoid Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Typhoid Vaccine market include Actiza Pharmaceutical, Bharat Biotec, Merit Pharmaceuticals, PaxVax, GlaxoSmithKline, Merck and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Typhoid Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Typhoid Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Typhoid Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Typhoid Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Typhoid Vaccine Segment by Company

Actiza Pharmaceutical

Bharat Biotec

Merit Pharmaceuticals

PaxVax

GlaxoSmithKline

Merck

Sanofi

Typhoid Vaccine Segment by Type

Oral Type Typhoid Vaccine

Injection Type Typhoid Vaccine

Typhoid Vaccine Segment by Application

Pharmaceutical & Biotechnology Companies

Hospital

Research & Academic Laboratories

Others

Typhoid Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Typhoid Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Typhoid Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Typhoid Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Typhoid Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Typhoid Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Typhoid Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Typhoid Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Typhoid Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Typhoid Vaccine industry.

Chapter 3: Detailed analysis of Typhoid Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Typhoid Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Typhoid Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Typhoid Vaccine Industry Trends Table 2. Typhoid Vaccine Industry Drivers Table 3. Typhoid Vaccine Industry Opportunities and Challenges Table 4. Typhoid Vaccine Industry Restraints Table 5. Global Typhoid Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Typhoid Vaccine Revenue Share by Company (2021-2026) Table 7. Global Typhoid Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Typhoid Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Typhoid Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Typhoid Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Typhoid Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Typhoid Vaccine Company, Product Type & Application Table 13. Global Typhoid Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Typhoid Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Type Typhoid Vaccine Table 18. Significant Companies of Injection Type Typhoid Vaccine Table 19. Global Typhoid Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Typhoid Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Typhoid Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Typhoid Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Typhoid Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Typhoid Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Typhoid Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Typhoid Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Typhoid Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Typhoid Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmaceutical & Biotechnology Companies Table 30. Significant Companies of Hospital Table 31. Significant Companies of Research & Academic Laboratories Table 32. Significant Companies of Others Table 33. Global Typhoid Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Typhoid Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Typhoid Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Typhoid Vaccine Sales Volume Share by Application (2021-2026) Table 37. Global Typhoid Vaccine Sales Volume Share by Application (2027-2032) Table 38. Global Typhoid Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Typhoid Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Typhoid Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Typhoid Vaccine Sales Value Share by Application (2021-2026) Table 42. Global Typhoid Vaccine Sales Value Share by Application (2027-2032) Table 43. Global Typhoid Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Typhoid Vaccine Sales by Region (2021-2026) & (K Units) Table 45. Global Typhoid Vaccine Sales Market Share by Region (2021-2026) Table 46. Global Typhoid Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global Typhoid Vaccine Sales Market Share by Region (2027-2032) Table 48. Global Typhoid Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Typhoid Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Typhoid Vaccine Sales Value Share by Region (2021-2026) Table 51. Global Typhoid Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Typhoid Vaccine Sales Value Share by Region (2027-2032) Table 53. Global Typhoid Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Typhoid Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Typhoid Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Typhoid Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 58. Global Typhoid Vaccine Sales Market Share by Country (2021-2026) Table 59. Global Typhoid Vaccine Sales by Country (2027-2032) & (K Units) Table 60. Global Typhoid Vaccine Sales Market Share by Country (2027-2032) Table 61. Global Typhoid Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Typhoid Vaccine Sales Value Market Share by Country (2021-2026) Table 63. Global Typhoid Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Typhoid Vaccine Sales Value Market Share by Country (2027-2032) Table 65. Actiza Pharmaceutical Company Information Table 66. Actiza Pharmaceutical Business Overview Table 67. Actiza Pharmaceutical Typhoid Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Actiza Pharmaceutical Typhoid Vaccine Product Portfolio Table 69. Actiza Pharmaceutical Recent Development Table 70. Bharat Biotec Company Information Table 71. Bharat Biotec Business Overview Table 72. Bharat Biotec Typhoid Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Bharat Biotec Typhoid Vaccine Product Portfolio Table 74. Bharat Biotec Recent Development Table 75. Merit Pharmaceuticals Company Information Table 76. Merit Pharmaceuticals Business Overview Table 77. Merit Pharmaceuticals Typhoid Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Merit Pharmaceuticals Typhoid Vaccine Product Portfolio Table 79. Merit Pharmaceuticals Recent Development Table 80. PaxVax Company Information Table 81. PaxVax Business Overview Table 82. PaxVax Typhoid Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. PaxVax Typhoid Vaccine Product Portfolio Table 84. PaxVax Recent Development Table 85. GlaxoSmithKline Company Information Table 86. GlaxoSmithKline Business Overview Table 87. GlaxoSmithKline Typhoid Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. GlaxoSmithKline Typhoid Vaccine Product Portfolio Table 89. GlaxoSmithKline Recent Development Table 90. Merck Company Information Table 91. Merck Business Overview Table 92. Merck Typhoid Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Merck Typhoid Vaccine Product Portfolio Table 94. Merck Recent Development Table 95. Sanofi Company Information Table 96. Sanofi Business Overview Table 97. Sanofi Typhoid Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Sanofi Typhoid Vaccine Product Portfolio Table 99. Sanofi Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Typhoid Vaccine Distributors List Table 103. Typhoid Vaccine Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Typhoid Vaccine Product Image Figure 2. Global Typhoid Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Typhoid Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Typhoid Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Typhoid Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Typhoid Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Type Typhoid Vaccine Image Figure 10. Injection Type Typhoid Vaccine Image Figure 11. Global Typhoid Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Typhoid Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Typhoid Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Typhoid Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Typhoid Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Typhoid Vaccine Sales Value Share by Type (2021-2032) Figure 17. Pharmaceutical & Biotechnology Companies Image Figure 18. Hospital Image Figure 19. Research & Academic Laboratories Image Figure 20. Others Image Figure 21. Global Typhoid Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Typhoid Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Typhoid Vaccine Sales Volume Share by Application (2021-2032) Figure 24. Global Typhoid Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Typhoid Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Typhoid Vaccine Sales Value Share by Application (2021-2032) Figure 27. Global Typhoid Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Typhoid Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Typhoid Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Typhoid Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Typhoid Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Typhoid Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Typhoid Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Typhoid Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Typhoid Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Typhoid Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Typhoid Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Typhoid Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Typhoid Vaccine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Typhoid Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Typhoid Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Typhoid Vaccine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Typhoid Vaccine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Type Typhoid Vaccine
  • Injection Type Typhoid Vaccine
Applications
  • Pharmaceutical & Biotechnology Companies
  • Hospital
  • Research & Academic Laboratories
  • Others
Companies covered
  • Actiza Pharmaceutical
  • Bharat Biotec
  • Merit Pharmaceuticals
  • PaxVax
  • GlaxoSmithKline
  • Merck
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Typhoid Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Typhoid Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Typhoid Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Typhoid Vaccine Market Dynamics
  1. 2.1 Typhoid Vaccine Industry Trends
  2. 2.2 Typhoid Vaccine Industry Drivers
  3. 2.3 Typhoid Vaccine Industry Opportunities and Challenges
  4. 2.4 Typhoid Vaccine Industry Restraints
3 Typhoid Vaccine Market by Company
  1. 3.1 Global Typhoid Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Typhoid Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Typhoid Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Typhoid Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Typhoid Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Typhoid Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Typhoid Vaccine Company Product Type and Application
  8. 3.8 Global Typhoid Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Typhoid Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Typhoid Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Typhoid Vaccine Market by Type
  1. 4.1 Typhoid Vaccine Type Introduction
  2. 4.1.1 Oral Type Typhoid Vaccine
  3. 4.1.2 Injection Type Typhoid Vaccine
  4. 4.2 Global Typhoid Vaccine Sales Volume by Type
  5. 4.2.1 Global Typhoid Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Typhoid Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Typhoid Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Typhoid Vaccine Sales Value by Type
  9. 4.3.1 Global Typhoid Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Typhoid Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Typhoid Vaccine Sales Value Share by Type (2021-2032)
5 Typhoid Vaccine Market by Application
  1. 5.1 Typhoid Vaccine Application Introduction
  2. 5.1.1 Pharmaceutical & Biotechnology Companies
  3. 5.1.2 Hospital
  4. 5.1.3 Research & Academic Laboratories
  5. 5.1.4 Others
  6. 5.2 Global Typhoid Vaccine Sales Volume by Application
  7. 5.2.1 Global Typhoid Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Typhoid Vaccine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Typhoid Vaccine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Typhoid Vaccine Sales Value by Application
  11. 5.3.1 Global Typhoid Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Typhoid Vaccine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Typhoid Vaccine Sales Value Share by Application (2021-2032)
6 Typhoid Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Typhoid Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Typhoid Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Typhoid Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Typhoid Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Typhoid Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Typhoid Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Typhoid Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Typhoid Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Typhoid Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Typhoid Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Typhoid Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Typhoid Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Typhoid Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Typhoid Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Typhoid Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Typhoid Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Typhoid Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Typhoid Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Typhoid Vaccine Sales Value Share by Country, 2025 VS 2032
7 Typhoid Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Typhoid Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Typhoid Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Typhoid Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Typhoid Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Typhoid Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Typhoid Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Typhoid Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Typhoid Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Typhoid Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Typhoid Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Typhoid Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Actiza Pharmaceutical
  2. 8.1.1 Actiza Pharmaceutical Company Information
  3. 8.1.2 Actiza Pharmaceutical Business Overview
  4. 8.1.3 Actiza Pharmaceutical Typhoid Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Actiza Pharmaceutical Typhoid Vaccine Product Portfolio
  6. 8.1.5 Actiza Pharmaceutical Recent Developments
  7. 8.2 Bharat Biotec
  8. 8.2.1 Bharat Biotec Company Information
  9. 8.2.2 Bharat Biotec Business Overview
  10. 8.2.3 Bharat Biotec Typhoid Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bharat Biotec Typhoid Vaccine Product Portfolio
  12. 8.2.5 Bharat Biotec Recent Developments
  13. 8.3 Merit Pharmaceuticals
  14. 8.3.1 Merit Pharmaceuticals Company Information
  15. 8.3.2 Merit Pharmaceuticals Business Overview
  16. 8.3.3 Merit Pharmaceuticals Typhoid Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merit Pharmaceuticals Typhoid Vaccine Product Portfolio
  18. 8.3.5 Merit Pharmaceuticals Recent Developments
  19. 8.4 PaxVax
  20. 8.4.1 PaxVax Company Information
  21. 8.4.2 PaxVax Business Overview
  22. 8.4.3 PaxVax Typhoid Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 PaxVax Typhoid Vaccine Product Portfolio
  24. 8.4.5 PaxVax Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Typhoid Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Typhoid Vaccine Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Typhoid Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Merck Typhoid Vaccine Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Sanofi
  38. 8.7.1 Sanofi Company Information
  39. 8.7.2 Sanofi Business Overview
  40. 8.7.3 Sanofi Typhoid Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi Typhoid Vaccine Product Portfolio
  42. 8.7.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Typhoid Vaccine Value Chain Analysis
  2. 9.1.1 Typhoid Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Typhoid Vaccine Sales Mode & Process
  6. 9.2 Typhoid Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Typhoid Vaccine Distributors
  9. 9.2.3 Typhoid Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst